Carnitine

Carnitine

SCHEMBL1462464

C[N+](C)(C)CC(O)CC(=O)[O-].N=C(N)NCCC[C@H](N)C(=O)OC(=O)[C@@H](N)CS

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ SLC22A16 Q86VW1 1/20 0.43
▸ CPT2 P23786 2/20 0.35
▸ CPT1A P50416 2/20 0.35
▸ CPT1B Q92523 1/20 0.34
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ NPY4R P50391 2/20 0.31
▸ NPY1R P25929 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ HRH1 P35367 1/20 0.30
▸ CRAT P43155 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL22577747 0.87 SLC22A16 (0.44) SLC22A16CPT2CPT1ACPT1BMEN1
Arginine SCHEMBL1462462 0.87 SLC22A16 (0.44) SLC22A16CPT2CPT1ACPT1BMEN1
SCHEMBL3487135 0.84 ALOX15 (0.36) MEN1KMT2ANPY4RNPY1RCYP1A2
Arginine SCHEMBL27902011 0.83 SLC22A16 (0.50) SLC22A16CPT2CPT1ACPT1BMEN1
Arginine SCHEMBL27492468 0.82 SLC22A16 (0.49) SLC22A16CPT2CPT1ACPT1BMEN1
SCHEMBL15549471 0.79 MEN1 (0.48) SLC22A16CPT2CPT1ACPT1BMEN1
Arginine SCHEMBL28276672 0.77 SLC22A16 (0.43) SLC22A16CPT2CPT1ACPT1B
SCHEMBL288133 0.77 NPY4R (0.39) MEN1KMT2ANPY4RNPY1RCYP1A2
SCHEMBL9237239 0.77 NPY4R (0.39) MEN1KMT2ANPY4RNPY1RCYP1A2
SCHEMBL28712062 0.77 NPY4R (0.39) MEN1KMT2ANPY4RNPY1RCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2494075-A2 TEMPLATED NANOCONJUGATES Northwestern University (US) 2012-09-05 — — EP disclosed
EP-2473160-A1 DELIVERY OF THERAPEUTIC AGENTS USING OLIGONUCLEOTIDE-MODIFIED NANOPARTICLES AS CARRIERS Northwestern University (US) 2012-07-11 — — EP disclosed
WO-2011053940-A2 TEMPLATED NANOCONJUGATES NORTHWESTERN UNIVERSITY (US) 2011-05-05 — — WO disclosed
WO-2011028850-A1 DELIVERY OF THERAPEUTIC AGENTS USING OLIGONUCLEOTIDE-MODIFIED NANOPARTICLES AS CARRIERS NORTHWESTERN UNIVERSITY (US) 2011-03-10 — — WO disclosed
Send feedback